We are live on
!
Find out more
AC
AKO Capital Portfolio holdings
AUM
$5.11B
1-Year Est. Return
2.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
-2.56%
3 Year Est. Return
+42.63%
5 Year Est. Return
+64.88%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
+$157M
(+9.3%)
Cap. Flow
+$86.1M
Cap. Flow
% of AUM
4.66%
Top 10 Holdings %
Top 10 Hldgs %
74.6%
Holding
19
New
1
Increased
14
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$34.1M |
| 2 |
Nike
NKE
|
+$26.4M |
| 3 |
Estee Lauder
EL
|
+$13.2M |
| 4 |
Fair Isaac
FICO
|
+$9.43M |
| 5 |
RTX Corp
RTX
|
+$9.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$40M |
| 2 |
GRFS
Grifois
GRFS
|
+$19.4M |
| 3 |
Moody's
MCO
|
+$4.46M |
| 4 |
US Bancorp
USB
|
+$4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.53% |
| 2 | Healthcare | 14.43% |
| 3 | Financials | 13.93% |
| 4 | Technology | 11.17% |
| 5 | Consumer Staples | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ferrari
RACE
$65.1B
| $496M | 26.86% |
3,657,381
-304,338
| -8% | -$40M |
|
|
GRFS
2
Grifois
GRFS
$5.27B
| $231M | 12.52% |
10,759,637
-889,997
| -8% | -$19.4M |
|
|
3
Estee Lauder
EL
$29.8B
| $102M | 5.54% |
717,459
+89,364
| +14% | +$13.2M |
|
4
Visa
V
$677B
| $98.1M | 5.3% |
740,305
+61,761
| +9% | +$7.95M |
|
|
PX
5
DELISTED
Praxair Inc
PX
| $80.7M | 4.37% |
510,405
+42,582
| +9% | +$6.58M |
|
|
6
Fair Isaac
FICO
$28.5B
| $78.1M | 4.23% |
403,978
+52,052
| +15% | +$9.43M |
|
7
Allegion
ALLE
$11.8B
| $74.9M | 4.05% |
968,660
+107,892
| +13% | +$8.64M |
|
8
Cognizant
CTSH
$20.6B
| $74.2M | 4.02% |
939,647
+78,393
| +9% | +$6.16M |
|
|
9
Nike
NKE
$63.7B
| $72.1M | 3.9% |
904,412
+374,448
| +71% | +$26.4M |
|
|
10
RTX Corp
RTX
$261B
| $70.7M | 3.82% |
898,135
+116,846
| +15% | +$9.15M |
|
11
Marriott International
MAR
$97B
| $69.8M | 3.78% |
551,342
+45,998
| +9% | +$6.25M |
|
12
Alphabet (Google) Class C
GOOG
$4.22T
| $67.8M | 3.67% |
1,215,800
+163,720
| +16% | +$8.85M |
|
13
CME Group
CME
$85.8B
| $63.6M | 3.44% |
387,999
+32,369
| +9% | +$5.29M |
|
|
ANSS
14
DELISTED
Ansys
ANSS
| $54.1M | 2.93% |
310,638
+25,843
| +9% | +$4.3M |
|
|
15
US Bancorp
USB
$99.2B
| $50.1M | 2.71% |
1,001,075
-78,839
| -7% | -$4M |
|
16
Colgate-Palmolive
CL
$72.4B
| $48.9M | 2.64% |
754,259
+62,927
| +9% | +$4.12M |
|
|
17
Moody's
MCO
$85.7B
| $45.7M | 2.47% |
267,966
-26,327
| -9% | -$4.46M |
|
|
18
Edwards Lifesciences
EW
$48.7B
| $35.4M | 1.92% |
+730,008
| New | +$34.1M |
|
19
Ambev
ABEV
$48.1B
| $34.1M | 1.84% |
7,356,066
+613,699
| +9% | +$3.61M |
|
Similar funds
CIA
EIC
TAM
BG
CS
PA
NC
VT
AKO Capital's Q2 2018 Portfolio in Review
As of Q2 2018, AKO Capital held 19 positions worth $1.85B, up 9.3% from $1.69B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
AKO Capital deployed $86.1M of net new capital in Q2 2018, opening 1 new position and adding to 14 existing holdings. Its largest new stake was Edwards Lifesciences: 730,008 shares worth $35.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ferrari, an estimated $40M trimmed.
- AKO Capital's largest Q2 2018 buy was Edwards Lifesciences: 730,008 shares worth $35.4M.
- AKO Capital added most to Nike in Q2 2018, an estimated $26.4M increase.
- AKO Capital's biggest Q2 2018 reduction was Ferrari, cutting an estimated $40M.
- AKO Capital's ten largest holdings make up 75% of its $1.85B portfolio in Q2 2018.
- AKO Capital opened 1 new position and closed 0 in Q2 2018.
- AKO Capital's portfolio value rose 9.3% quarter-over-quarter to $1.85B.
Based on AKO Capital's 13F filing for Q2 2018, filed 9 Aug 2018.